Company / Working Capital per Share
Processa Pharmaceuticals, Inc. Working Capital per Share History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.47
FY2022
5-year range
-$0.21 / $1.22
FY2018-FY2022
Trend
-61.6%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has fluctuated over the past 6 years, ranging from $-0.33 in FY2013 to $1.22 in FY2021.
Based on SEC 10-K filings.
0.47 in FY2022.
Improved from $-0.21 to $0.47 over the past 6 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, working capital per share decreased 61.6% year-over-year.
- Peak working capital per share was recorded in FY2021.
- Lowest working capital per share in the period was in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.47 | -61.6% |
| FY2021 | $1.22 | +673.5% |
| FY2016 | -$0.21 | -18.1% |
| FY2015 | -$0.18 | -216.9% |
| FY2014 | -$0.06 | +82.7% |
| FY2013 | -$0.33 | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026